483
Mark Vishnepolsky, M.D.Mark Vishnepolsky, M.D. – FDA 483, Jun 9, 2026
Record Details
An FDA inspection of Mark Vishnepolsky, M.D. in Las Vegas, NV, revealed significant deficiencies in clinical investigation practices. The firm failed to adhere to the investigational plan by enrolling ineligible subjects and did not promptly report serious adverse events to the sponsor. Additionally, inadequate and inaccurate case histories were maintained, indicating a systemic lack of proper documentation and oversight in the clinical trial.
View Company Profile
ID · eb2b817b-882d-4417-ac73-26d360f8ec94
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.